II 型髁上骨折的临床试验
总计1654个结果
-
Novartis Pharmaceuticals完全的
-
Celio Technology Inc.完全的
-
Taichung Veterans General Hospital未知
-
Forest LaboratoriesPhenomix终止
-
Basque Culinary Center FundazioaUniversity of Navarra完全的
-
Hoffmann-La RocheRoche Diabetes Care Deutschland GmbH完全的
-
Walter Reed National Military Medical Center完全的
-
Sultan Qaboos UniversityKarolinska Institutet; Nova Biomedical招聘中
-
Chong Kun Dang Pharmaceutical完全的
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Joslin Diabetes CenterMassachusetts Institute of Technology完全的
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research Institute未知
-
Medical University of Vienna完全的
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and Development未知
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.未知
-
Ferzli, George S., M.D. F.A.C.S.未知
-
McMaster University尚未招聘肥胖 | 溶酶体贮积病 | 肌肉流失 | 糖原贮积病 II 型 | 庞贝病 | 营养不良 | 糖原贮积病 II 型,成人 | II 型迟发性糖原累积病
-
Genzyme, a Sanofi Company终止糖原贮积症 2 | 糖原贮积病 II 型 (GSD II) | 酸性麦芽糖酶缺乏症 | 庞贝病(婴儿发病)美国, 台湾, 德国
-
Genzyme, a Sanofi Company完全的
-
Genzyme, a Sanofi Company完全的